Rapamycin arrested cell cycle in G1 phase to antitumor by degrading the CDK-cyclin complexes kinase activity.

• Rapamycin 还能通过降低CDK-cyclin 复合物激酶的活性,使细胞周期阻滞在G1期,从而发挥抗肿瘤的作用。